Publications by authors named "Rodger D Curren"

Claim this Profile
V
Validation of the 3D reconstructed human skin micronucleus (RSMN) assay: an animal-free alternative for following-up positive results from standard in vitro genotoxicity assays.
Stefan Pfuhler, Thomas R Downs, Nicola J Hewitt, Sebastian Hoffmann, Greg C Mun, Rodger D Curren

Mutagenesis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of New Test Methods into Practical Testing.
Rodger D Curren, Albrecht Poth, Hans A Raabe

Adv Exp Med Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local tolerance testing under REACH: Accepted non-animal methods are not on equal footing with animal tests.
Ursula G Sauer, Erin H Hill, Rodger D Curren, Hans A Raabe, Susanne N Kolle

Altern Lab Anim· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of chemicals requiring metabolic activation in the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay.
Marilyn J Aardema, Brenda B Barnett, Greg C Mun, Erica L Dahl, Rodger D Curren

Mutat Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility.
Marilyn J Aardema, Brenda C Barnett, Zubin Khambatta, Kerstin Reisinger, Gladys Ouedraogo-Arras, Rodger D Curren

Mutat Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay.
Ting Hu, Yulia Kaluzhny, Greg C Mun, Brenda Barnett, Viktor Karetsky, Rodger D Curren

Mutat Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay.
Greg C Mun, Marilyn J Aardema, Ting Hu, Brenda Barnett, Yulia Kaluzhny, Rodger D Curren

Mutat Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
Richard A Becker, Christopher J Borgert, Simon Webb, Jay Ansell, Sara Amundson, Rodger D Curren

Regul Toxicol Pharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm).
Rodger D Curren, Greg C Mun, David P Gibson, Marilyn J Aardema

Mutat Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of some in vitro tests to reduce and replace the sub-acute animal toxicity studies.
Rajendra S Chhabra, Nancy B Ress, John W Harbell, Rodger D Curren

Altern Lab Anim· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular safety: a silent (in vitro) success story.
Rodger D Curren, John W Harbell

Altern Lab Anim· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. The European Centre for the Validation of Alternative Methods Skin Irritation Task Force report 2.
Valérie Zuang, Michael Balls, Philip A Botham, Alain Coquette, Emanuela Corsini, Rodger D Curren

Altern Lab Anim· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis